Sarepta Therapeutics to Announce Third Quarter 2023 Financial Results

Rhea-AI Summary

Sarepta Therapeutics, Inc. will report its third quarter 2023 financial results on November 1, 2023. The company will host a conference call to discuss the results and a webcast will be available on their website.

Positive

• Sarepta Therapeutics will report its Q3 2023 financial results, which could positively impact stock price if the results exceed expectations.

Negative

• None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2023 financial results after the Nasdaq Global Market closes on Wednesday, Nov. 1, 2023. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its third quarter 2023 financial results.

The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form. After registering for dial-in details, all phone participants will receive an auto-generated e-mail containing a link to the dial-in number along with a personal PIN number to use to access the event by phone.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231025578048/en/

Investor Contact:

Ian Estepan, 617-274-4052

iestepan@sarepta.com

Media Contact:

Tracy Sorrentino, 617-301-8566

tsorrentino@sarepta.com

Source: Sarepta Therapeutics, Inc.

FAQ

When will Sarepta Therapeutics report its Q3 2023 financial results?

Sarepta Therapeutics will report its Q3 2023 financial results on November 1, 2023.

Where can I listen to the conference call discussing the Q3 2023 financial results?

You can listen to the conference call discussing the Q3 2023 financial results on Sarepta Therapeutics' website under the investor relations section.

Will there be a replay of the conference call available?

Yes, a replay of the conference call will be archived on Sarepta Therapeutics' website for one year.

How can I participate in the conference call by phone?

To participate in the conference call by phone, you need to register using the online form provided by Sarepta Therapeutics. After registering, you will receive an auto-generated email with the dial-in number and a personal PIN number to access the call.